ArticleBreast cancer research and treatment2022

Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.

Thi Truc Anh Nguyen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.